Design, conduct, and analysis of clinical trials in disease due to methicillin-resistant Staphylococcus aureus (Q84465719)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19707216%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Design, conduct, and analysis of clinical trials in disease due to methicillin-resistant Staphylococcus aureus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19707216%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

main subject

Staphylococcus aureus

1 reference

J H Powers

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19707216%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

T R Fleming

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19707216%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

1 September 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19707216%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

6 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19707216%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

86

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19707216%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19707216%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

244-247

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19707216%20AND%20SRC:MED&resulttype=core&format=json

Increasing the efficiency of clinical trials of antimicrobials: the scientific basis of substantial evidence of effectiveness of drugs

6 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.132

7 January 2021

Statistics in medicine--reporting of subgroup analyses in clinical trials.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.132

7 January 2021

Drotrecogin Alfa (activated) Improves In-hospital and 90-day Survival in Patients With Severe Sepsis and Community-acquired Pneumoni

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.132

7 January 2021

Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.132

7 January 2021

Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.132

7 January 2021

Issues in noninferiority trials: the evidence in community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.132

7 January 2021

Does this patient have ventilator-associated pneumonia?

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.132

7 January 2021

Rapid diagnostics for methicillin-resistant Staphylococcus aureus: current status

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.132

7 January 2021

Identifiers

DOI

10.1038/CLPT.2009.132

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19707216%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference